Bavarian Nordic A/S
BAVA
Rang in Aktien
#5046
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Aktienkurs
$37.76
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$2.87B
Veränderung (1 Tag)
-0.17%
Veränderung (1 Jahr)
1.44%
Land
DK
Handel Bavarian Nordic A/S (BAVA)
Kategorie
Healthcare
Marktkapitalisierung von Bavarian Nordic A/S(BAVA)
Marktkapitalisierung: $2.87B
Mit Stand October 2026 hat Bavarian Nordic A/S eine Marktkapitalisierung von $2.87B. Das macht Bavarian Nordic A/S laut unseren Daten zum 5046th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Bavarian Nordic A/S von 2003 bis 2026
BAVA im Vergleich zu den Top 5 der beliebtesten stocks
